Sonic hedgehog in normal and neoplastic proliferation: insight gained from human tumors and animal models.

Cancer arises when a cell accumulates multiple genetic changes that allow it to elude the highly regulated balance between proliferation and apoptosis that an organism employs to suppress inappropriate growth. It has become evident that malignant transformation of a cell or group of cells often involves pathways that are active during normal development but are inappropriately regulated in neoplastic proliferation. Signaling via the Sonic hedgehog pathway is critical to vertebrate development and also appears to play an integral role in the initiation and propagation of some tumors of the muscle, skin and nervous system. Analyses of human tumors have revealed mutations in various components of the Sonic hedgehog signaling pathway that appear to result in the activation of this pathway, as inferred by the increased expression of the transcription factor, Gli1. Interestingly, a proportion of the human tumors and most of those arising in mouse models continue to express the normal Patched allele, suggesting the involvement of additional molecular events in the transformation of the haploinsufficient cells.

[1]  Dan Goldowitz,et al.  The cells and molecules that make a cerebellum , 1998, Trends in Neurosciences.

[2]  R. Gilbertson Paediatric embryonic brain tumours. biological and clinical relevance of molecular genetic abnormalities. , 2002, European journal of cancer.

[3]  F. McCormick,et al.  A frequent activated smoothened mutation in sporadic basal cell carcinomas , 1999, Oncogene.

[4]  J. Taipale,et al.  Patched acts catalytically to suppress the activity of Smoothened , 2002, Nature.

[5]  H. Weiner,et al.  The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. , 2001, Development.

[6]  Q. Gu,et al.  Activating Smoothened mutations in sporadic basal-cell carcinoma , 1998, Nature.

[7]  L. Wojnowski,et al.  Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome , 1998, Nature Medicine.

[8]  M. Scott,et al.  The developmental biology of brain tumors. , 2001, Annual review of neuroscience.

[9]  M. Scott,et al.  Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. , 1998, The Journal of investigative dermatology.

[10]  A. Bale,et al.  Developmental genes and cancer: role of patched in basal cell carcinoma of the skin. , 1997, Journal of the National Cancer Institute.

[11]  M. Scott,et al.  Sonic hedgehog in the nervous system: functions, modifications and mechanisms , 2002, Current Opinion in Neurobiology.

[12]  M. Scott,et al.  Hedgehog and Patched in Neural Development and Disease , 1998, Neuron.

[13]  D. Donoghue,et al.  Patched1 interacts with cyclin B1 to regulate cell cycle progression , 2001, The EMBO journal.

[14]  Y. Nakamura,et al.  Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. , 1999, Human molecular genetics.

[15]  V. P. Collins,et al.  Somatic mutations in the human homologue of Drosophila patched in primitive neuroectodermal tumours , 1997, Oncogene.

[16]  A. Bale,et al.  The hedgehog pathway and basal cell carcinomas. , 2001, Human molecular genetics.

[17]  M. Scott,et al.  Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine , 2000, Nature.

[18]  T. Jacks,et al.  Cancer Modeling in the Modern Era Progress and Challenges , 2002, Cell.

[19]  T Pietsch,et al.  Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. , 1997, Cancer research.

[20]  G. Chenevix-Trench,et al.  Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. , 1997, American journal of human genetics.

[21]  R. Myers,et al.  Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.

[22]  Michael Dean,et al.  Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome , 1996, Cell.

[23]  T. Poggio,et al.  Prediction of central nervous system embryonal tumour outcome based on gene expression , 2002, Nature.

[24]  C. Potter,et al.  Drosophila in cancer research. An expanding role. , 2000, Trends in genetics : TIG.

[25]  F. Sauvage,et al.  Sonic hedgehog signaling by the Patched–Smoothened receptor complex , 1999, Current Biology.

[26]  James M. Olson,et al.  Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade , 2002, Science.

[27]  C. Hui,et al.  Basal cell carcinomas in mice overexpressing Gli2 in skin , 2000, Nature Genetics.

[28]  A. Goldstein,et al.  Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. , 1997, American journal of medical genetics.

[29]  A. Berns,et al.  Haplo-insufficiency? Let me count the ways. , 2001, Genes & development.

[30]  A. Joyner,et al.  Gli genes in development and cancer , 1999, Oncogene.

[31]  M. Rosemann,et al.  Unbalanced overexpression of the mutant allele in murine Patched mutants. , 2002, Carcinogenesis.

[32]  T. Curran,et al.  The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched. , 2000, Cancer research.

[33]  Karlyne M. Reilly,et al.  Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum , 2002, Oncogene.

[34]  S. Pazzaglia,et al.  High incidence of medulloblastoma following X-ray-irradiation of newborn Ptc1 heterozygous mice , 2002, Oncogene.

[35]  W. Cook,et al.  Accommodating haploinsufficient tumour suppressor genes in Knudson's model , 2000, Oncogene.

[36]  P. Sánchez,et al.  Gli and hedgehog in cancer: tumours, embryos and stem cells , 2002, Nature Reviews Cancer.

[37]  E. Pivnick,et al.  Complications of the nevoid basal cell carcinoma syndrome: a case report. , 1997, Journal of pediatric hematology/oncology.

[38]  L. Rorke,et al.  Medulloblastoma: clinical and biologic aspects. , 1999, Neuro-oncology.

[39]  W. Hahn,et al.  Modelling the molecular circuitry of cancer , 2002, Nature Reviews Cancer.

[40]  M. Scott,et al.  Mutations of the PATCHED gene in several types of sporadic extracutaneous tumors. , 1997, Cancer research.

[41]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[42]  M. Scott,et al.  Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice , 2000, Genes, chromosomes & cancer.

[43]  Paul A. Khavari,et al.  Induction of basal cell carcinoma features in transgenic human skin expressing Sonic Hedgehog , 1997, Nature Medicine.

[44]  D. Rowitch,et al.  Sonic hedgehog Promotes G1 Cyclin Expression and Sustained Cell Cycle Progression in Mammalian Neuronal Precursors , 2000, Molecular and Cellular Biology.

[45]  Paola Bovolenta,et al.  Sonic hedgehog in CNS development: one signal, multiple outputs , 2002, Trends in Neurosciences.

[46]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[47]  P. Rakić,et al.  Neuronal migration, with special reference to developing human brain: a review. , 1973, Brain research.

[48]  C. Sherr Cancer Cell Cycles , 1996, Science.

[49]  D. Gutmann,et al.  Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation , 1999, Oncogene.

[50]  M. Scott,et al.  Vertebrate homologs of Drosophila suppressor of fused interact with the gli family of transcriptional regulators. , 1999, Developmental biology.

[51]  R. Kapur,et al.  Cyclopamine inhibition of Sonic hedgehog signal transduction is not mediated through effects on cholesterol transport. , 2000, Developmental biology.

[52]  Paul A. Khavari,et al.  Sonic Hedgehog Opposes Epithelial Cell Cycle Arrest , 1999, The Journal of cell biology.

[53]  D. Krause,et al.  Alternative first exons of PTCH1 are differentially regulated in vivo and may confer different functions to the PTCH1 protein , 2002, Oncogene.

[54]  Andreas Zimmer,et al.  Patched Target Igf2 Is Indispensable for the Formation of Medulloblastoma and Rhabdomyosarcoma* , 2000, The Journal of Biological Chemistry.

[55]  C. James,et al.  Sporadic medulloblastomas contain PTCH mutations. , 1997, Cancer research.

[56]  A. Joyner,et al.  Gli2, but not Gli1, is required for initial Shh signaling and ectopic activation of the Shh pathway. , 2002, Development.

[57]  A. Bale Hedgehog signaling and human disease. , 2002, Annual review of genomics and human genetics.

[58]  D. Krause,et al.  Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  N. Dahmane,et al.  Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours , 1997, Nature.

[60]  Norbert Perrimon,et al.  Hedgehog signal transduction: recent findings. , 2002, Current opinion in genetics & development.

[61]  M. Wolter,et al.  Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. , 1997, Cancer research.

[62]  M. Scott,et al.  Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice , 1999, Nature Medicine.

[63]  M. Scott,et al.  Basal cell carcinomas in mice overexpressing sonic hedgehog. , 1997, Science.

[64]  M. Scott,et al.  Control of Neuronal Precursor Proliferation in the Cerebellum by Sonic Hedgehog , 1999, Neuron.

[65]  Michael Dean,et al.  Is human patched the gatekeeper of common skin cancers? , 1996, Nature Genetics.

[66]  C. Hui,et al.  Dissecting the oncogenic potential of Gli2: deletion of an NH(2)-terminal fragment alters skin tumor phenotype. , 2002, Cancer research.

[67]  P. Ingham,et al.  Hedgehog signaling in animal development: paradigms and principles. , 2001, Genes & development.

[68]  David Hogg,et al.  Mutations in SUFU predispose to medulloblastoma , 2002, Nature Genetics.

[69]  M. Nakafuku,et al.  Mouse Suppressor of fused is a negative regulator of Sonic hedgehog signaling and alters the subcellular distribution of Gli1 , 1999, Current Biology.

[70]  A. Gurney,et al.  Control of Cell Pattern in the Neural Tube by the Zinc Finger Transcription Factor and Oncogene Gli-1 , 1997, Neuron.

[71]  R. Cardiff,et al.  Genetic background affects susceptibility to mammary hyperplasias and carcinomas in Apc(min)/+ mice. , 2001, Cancer research.

[72]  D. Pinkel,et al.  Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation , 1998, The EMBO journal.

[73]  T. Curran,et al.  Loss of p53 but not ARF accelerates medulloblastoma in mice heterozygous for patched. , 2001, Cancer research.

[74]  Robert J. Gorlin,et al.  Nevoid Basal‐Cell Carcinoma Syndrome , 1987, Medicine.

[75]  C. Tabin,et al.  Ptc1 and Ptc2 transcripts provide distinct readouts of Hedgehog signaling activity during chick embryogenesis. , 2001, Developmental biology.